<DOC>
	<DOCNO>NCT00275678</DOCNO>
	<brief_summary>This study compare outcome study participant peripheral blood stem cell transplantation bone marrow transplantation unrelated donor treatment serious hematological malignancy .</brief_summary>
	<brief_title>Comparison Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation Treatment Serious Hematological Malignancies</brief_title>
	<detailed_description>This study randomize , open-label , multicenter , prospective , comparative trial granulocyte colony stimulate factor ( G-CSF ) mobilize peripheral blood stem cell verse marrow unrelated donor transplantation patient hematologic malignancy . The study compare two-year survival probability process many step match donor found . The donor also need give permission join study . Participants randomize either peripheral blood stem cell ( PBSC ) bone marrow . The kind transplant participant receive random . Neither participant doctor may choose type transplant . Participants receive vaccination diphtheria , tetanus , hepatitis B pneumococcus . Blood sample draw part participant 's normal care . Blood sample also collect see infection fight cell work . These sample collect 12 week , one year yearly three year post transplant . Information collect participant 's medical history . Participants also phone interview conduct question ask physical emotional health . Participants take part study may follow 5 year .</detailed_description>
	<criteria>Participants may eligible age 18 66 year undergo unrelated blood stem cell transplantation first time treatment hematological malignancy . Additional eligibility criterion gather evaluated transplant physician determine individual eligible take part .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>